CODX vs HSIC · rev $3.9M vs P/E 24, rev $12.67B
Co-Diagnostics, Inc. Common Stock (CODX) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
CODX currently screens at market cap $31.4M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the CODX and HSIC stock pages for the full models.
Not investment advice.